LeMaitre Vascular, Inc.
LMATNASDAQHealthcareMedical Instruments & Supplies
As of Oct 16, 2026 close
- Market cap
- $2.04B
- P/E (TTM)
- 31.11
- Forward P/E
- 21.59
- Dividend yield
- 1.14%
- 52-week range
- $78.22$118.01
- Volume (live)
- -
- Avg. volume (3M)
- 264.35K
LeMaitre Vascular (LMAT) Stock Price & Financial Analysis
LeMaitre Vascular Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $80.69 - $84.24 |
|---|---|
| 52-Week High | $118.01 |
| 52-Week Low | $78.22 |
| Open | $82.53 |
| Volume (last close) | 311.55K |
| Average Volume (3M) | 264.35K |
| Revenue (TTM) | 262.43M |
|---|---|
| Net Income (TTM) | 65.67M |
| Free Cash Flow (TTM) | 73.83M |
| EPS (TTM) | $2.77 |
| Profit Margin | 25.02% |
| Operating Margin | 29.46% |
| Return on Equity (ROE) | 15.62% |
| Debt to Equity | 0.41 |
| Annual Dividend | $0.95 |
|---|---|
| Dividend Yield | 1.14% |
| Payout Ratio | 34.33% |
| Last Dividend Ex-Date | Aug 20, 2026 |
| Market Cap | 2.04B |
|---|---|
| Shares Outstanding | 24.53M |
| P/E Ratio (TTM) | 31.11 |
| Forward P/E | 21.59 |
| Price to Sales (P/S) | 7.79 |
| Price to Book (P/B) | 4.86 |
| EV/EBITDA | 21.79 |
| 50-Day MA | $80.83 |
|---|---|
| 200-Day MA | $94.46 |
| 1-Year Change | −3.83% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
LeMaitre Vascular at a Glance
As of the Oct 16, 2026 close, LeMaitre Vascular (LMAT) has a market capitalization of $2.04B. The stock trades at 31.1× trailing earnings, 21.6× forward earnings and 7.8× sales. Over the trailing twelve months it earned $65.67M on revenue of $262.43M (a 25.0% profit margin) and generated $73.83M of free cash flow. Revenue grew 11.8% year over year.
As of its latest reported balance sheet, it holds $26.63M in cash and securities against $172.53M of debt, a net debt position of $145.91M.
LeMaitre Vascular pays a quarterly dividend totaling $0.95 per share a year, a 1.14% yield at the Oct 16, 2026 close, with a 34% payout ratio and 14 consecutive years of dividend increases.
The share price is down 3.8% over the past year. At $80.82 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $78.22 to $118.01, below its 200-day moving average of $94.46.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $97.50, 20.6% above the Oct 16, 2026 close.
Frequently Asked Questions About LeMaitre Vascular
What is the current stock price for LMAT?
As of the Oct 16, 2026 close, LMAT stock trades at $80.82. The 52-week range is $78.22–$118.01, with a day range of $80.69–$84.24.
What is the P/E ratio for LMAT?
As of the Oct 16, 2026 close, LeMaitre Vascular's trailing twelve-month (TTM) P/E ratio is 31.1, meaning investors pay $31.1 for every $1 of annual earnings. The forward P/E is 21.6, reflecting analyst expectations for future earnings. LeMaitre Vascular operates in the Healthcare sector.
Does LMAT pay dividends?
Yes, LeMaitre Vascular pays a 1.14% annual dividend yield as of the Oct 16, 2026 close ($0.95 per share a year). The trailing twelve-month payout ratio is 34.3%. The most recent ex-dividend date was August 20, 2026.
What do analysts recommend for LMAT?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for LMAT is Hold. The average 12-month price target is $97.50, a 20.6% upside from the Oct 16, 2026 close of $80.82.
What is the market cap of LMAT?
As of the Oct 16, 2026 close, LeMaitre Vascular's market capitalization is $1.98B, classifying it as a small-cap company. LeMaitre Vascular operates in the Healthcare sector within the Medical Instruments & Supplies industry.